MYH14 and central nervous system cancer: Blebbistatin, a cell-permeable suppressor of class-II myosins, was developed to study the biologic roles of myosin II [74] and inhibition of glioma invasion [75, 76] due to its high affinity and selectivity toward myosin II [77].